Research map: Progressive impairment of bioengineered skeletal muscles by MASLD-derived factors: a platform to model liver-induced muscle wasting

Back to the article

Papers in this map

  1. Fiji: an open-source platform for biological-image analysis · Johannes Schindelin · 2012 · 73297 citations · Cited by this paper
  2. First person – Armando Cortés-Reséndiz · 2026 · Cites this paper
  3. Nestin/CXCL12 immunohistochemistry and RNA sequencing map the bone marrow microenvironment in aplastic anemia · 2026 · Related
  4. Cellpose: a generalist algorithm for cellular segmentation · Carsen Stringer · 2020 · 4690 citations · Cited by this paper
  5. Transcriptomic and proteomic insights into progressive myoclonus epilepsy type 1 · 2026 · Related
  6. Sarcopenia: revised European consensus on definition and diagnosis · Alfonso José Cruz-Jentoft · 2019 · 3491 citations · Cited by this paper
  7. Spinning leukaemic cells to study their drug resistance · 2026 · Related
  8. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review · Zobair M. Younossi · 2023 · 3310 citations · Cited by this paper
  9. An antioxidant therapy elicits distinct transcriptome responses in 22q11-deleted upper layer cortical projection neurons · 2026 · Related
  10. Mechanisms of hepatic stellate cell activation · Takuma Tsuchida · 2017 · 2966 citations · Cited by this paper
  11. Hyperpolarised magnetic resonance spectroscopy with lab-on-a-chip disease models · 2026 · Related
  12. LC3 and Autophagy · Isei Tanida · 2008 · 1810 citations · Cited by this paper
  13. Folate and magnesium rescue developmental toxicity of HIV drug · 2026 · Related
  14. Relationship of Interleukin-6 and Tumor Necrosis Factor- With Muscle Mass and Muscle Strength in Elderly Men and Women: The Health ABC Study · Marjolein Visser · 2002 · 1305 citations · Cited by this paper
  15. Clarifying Frizzled 2 function in development through genetically validated mouse models · 2026 · Related
  16. Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease · Jennifer E. Lambert · 2013 · 1097 citations · Cited by this paper
  17. Gut-derived Unpaired-3 cytokine signaling promotes systemic hypoxia tolerance in Drosophila · 2026 · Related
  18. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis · Liang‐Guo Xu · 2004 · 1040 citations · Cited by this paper
  19. Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology · 2026 · Related
  20. Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis · Peter S. Zammit · 2017 · 932 citations · Cited by this paper
  21. Inflammatory responses following CRISPR modification of the nuclear localisation sequence in endogenous interleukin-1 alpha · 2026 · Related
  22. Trends in insulin resistance: insights into mechanisms and therapeutic strategy · Mengwei Li · 2022 · 922 citations · Cited by this paper
  23. IL-6 pathway in the liver: From physiopathology to therapy · Dirk Schmidt‐Arras · 2016 · 896 citations · Cited by this paper
  24. Epidemiology of metabolic dysfunction-associated steatotic liver disease · Zobair M. Younossi · 2024 · 876 citations · Cited by this paper
  25. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review · Wah‐Kheong Chan · 2023 · 761 citations · Cited by this paper
  26. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis · Stefano Ballestri · 2015 · 738 citations · Cited by this paper
  27. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. · Fabrizio De Benedetti · 1997 · 537 citations · Cited by this paper
  28. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis · Aldo J. Montaño‐Loza · 2015 · 515 citations · Cited by this paper
  29. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes · Swati Joshi‐Barve · 2007 · 413 citations · Cited by this paper
  30. Sarcopenia and frailty in decompensated cirrhosis · Puneeta Tandon · 2021 · 411 citations · Cited by this paper
  31. Updated mechanisms of MASLD pathogenesis · Yuxuan Li · 2024 · 295 citations · Cited by this paper
  32. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human · Tommy B. Andersson · 2012 · 261 citations · Cited by this paper
  33. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis · Rahima A. Bhanji · 2017 · 261 citations · Cited by this paper
  34. A Model to Identify Sarcopenia in Patients With Cirrhosis · Puneeta Tandon · 2016 · 251 citations · Cited by this paper
  35. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer · Krasimira Aleksandrova · 2014 · 215 citations · Cited by this paper
  36. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis · Rahima A. Bhanji · 2018 · 214 citations · Cited by this paper
  37. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary · Frank Tacke · 2024 · 206 citations · Cited by this paper
  38. Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases · Reddemma Sandireddy · 2024 · 206 citations · Cited by this paper
  39. Impact of different ectopic fat depots on cardiovascular and metabolic diseases · Daniele Ferrara · 2019 · 198 citations · Cited by this paper

Source: OpenAlex (CC0)